BC Week In Review | Sep 24, 2012
Company News

Roche sales and marketing update

Roche launched its Cobas AmpliPrep/Cobas TaqMan CMV Test in the U.S. as an aid in managing solid organ transplant patients who are undergoing anti-cytomegalovirus (CMV) therapy. The in vitro nucleic acid amplification test quantifies CMV...
BC Week In Review | Jul 16, 2012
Clinical News

Cobas AmpliPrep/Cobas TaqMan CMV Test regulatory update

FDA approved a PMA from Roche for its Cobas AmpliPrep/Cobas TaqMan CMV Test as an aid in managing solid organ transplant patients who are undergoing anti-cytomegalovirus (CMV) therapy. Roche plans to launch the test in...
BC Week In Review | Apr 11, 2011
Clinical News

Cobas AmpliPrep/Cobas TaqMan CMV Test regulatory update

Roche received CE mark approval in the EU for its Cobas AmpliPrep/Cobas TaqMan CMV Test as an aid in diagnosing and managing cytomegalovirus (CMV) infection. Roche said the product is already available in Europe. The...
Items per page:
1 - 3 of 3